Skip Main Navigation
Page Content

Save This Event

Event Saved

Looks like this event has already ended.

Check out upcoming events by this organizer, or organize your very own event.

View upcoming events Create an event

2019 Cancer Symposium: Advances in Colorectal Cancer Treatment

Inspira Health - Continuing Medical Education Program

Thursday, September 26, 2019 from 4:30 PM to 8:00 PM (EDT)

2019 Cancer Symposium: Advances in Colorectal Cancer...

Registration Information

Use promotional code to access registration.

Share 2019 Cancer Symposium: Advances in Colorectal Cancer Treatment

Event Details

2019 Cancer Symposium:

Advances in Colorectal Cancer Treatment



In the United States, colorectal cancer is the third leading cause of cancer-related deaths in men and in women, and the second most common cause of cancer deaths when men and women are combined. It is expected to cause about 51,020 deaths during 2019.

The patient population Inspira Health services requires education and screenings for the early detection and treatment of colorectal cancer. Advances in colorectal cancer treatment options and strategies will allow healthcare practitioners to deliver patient care that is tailored to individual treatment plans.

The 2019 Cancer Symposium has been designed as a live activity to address innovations in colorectal cancer treatment and therapies. Healthcare practitioners will benefit from an overview of current procedures and therapeutic options so they may expand their ability to assess and deliver the optimum spectrum of cancer care.


Multi-Disciplinary Approach to Rectal Cancer

New surgical approaches such as transanal endoscopic surgery and robotic surgery are just some of the innovative options to a multi-disciplinary approach to treating patients with rectal cancer. Important results of recent clinical trials to interpret the efficacy of laparoscopic versus open surgery, lateral pelvic lymph node dissection (LLND), preoperative and postoperative therapy, and a cautious approach to outcomes are also developing. With these new approaches to treatment it is important for the medical community to continue to expand their knowledge on current research and procedures. This presentation will address the current protocols and supporting research for a multi-disciplinary approach to managing rectal cancer.

As a result of attending this activity, participants should be able to:

  • Discuss the current literature supporting a multi-disciplinary approach to rectal cancer.
  • Identify the current standardized protocols for managing rectal cancer.
  • Describe the requirements for obtaining certification for a Rectal Cancer Center of Excellence.

 What’s New in the Treatment of Metastatic Colorectal Cancer? A lot!

Since the clinical introduction of 5-FU in the 1950s and subsequent introduction of the oral prodrug capecitabine, improvements in the treatment of colon cancer have been modest, with an emphasis on the administration of 5-FU in the adjuvant setting in combination regimens with leucovorin and oxaliplatin . The decision on whether to administer adjuvant chemotherapy to patients and the specific types of regimens used is often based on patient comorbidities and associated toxicity profiles of the individual agents. Chemotherapy treatment options and advancements will be explored in this lecture. 

 As a result of attending this activity, participants should be able to:

  • Review new data regarding initial therapy of metastatic colorectal cancer.
  • Summarize advances in treatment of refractory metastatic colorectal cancer.
  • Illustrate the evaluation and treatment of molecular subsets of metastatic colorectal cancer.

 The Radiation Oncologist's Role in Colorectal Cancer: Current & Upcoming Indications

Multimodal treatment approaches are indispensable for patients with advanced-stage colorectal cancer. Radiotherapy has been established as an essential part of perioperative concepts and was introduced as an option to face challenges such as local relapse or oligometastases. Radiation treatment for colorectal cancer is predominately focused on rectal cancer and has long been considered an important adjunct in the treatment of rectal cancer. A major outcome of importance for rectal cancer is local control. Parallel to improvements in surgical technique, adjuvant therapy regimens have been tested in clinical trials in an effort to reduce the local recurrence rate. Currently, the local recurrence rate has been reduced because of both good surgical techniques and the addition of radiotherapy. Based on recent reports in the literature, preoperative chemoradiotherapy is now considered the standard of care for patients with stages II and III rectal cancer. Also, short-course radiotherapy appears to provide effective local control and the same overall survival as more long-course chemoradiotherapy schedules and, therefore, may be an appropriate choice in some situations. A discussion of radiation oncology treatment options and appropriate indications will be highlighted including targeted combinations for personalized therapy.

  As a result of attending this activity, participants should be able to:

  • Identify patients with colorectal cancer who require radiation.
  • Explain the differences among types of radiation therapy
  • Discuss upcoming advances in radiation oncology for patients with colorectal cancer.




 Jonathan Efron, MD, FACS, FASCRS

Associate Professor of Surgery

The Mark M. Ravitch Endowed Professorship in Surgery

Chief of the Ravitch Division of GI Surgery

Interim Director of the Department of Surgery

Johns Hopkins University

Baltimore, MD


 Steven Cohen, MD

Medical Director, Asplundh Cancer Pavilion

Chief, Medical Oncology and Hematology Division

Abington Hospital-Jefferson Health

Vice-Chair, Department of Medical Oncology

Sidney Kimmel Cancer Center at Jefferson

Professor of Medical Oncology, Thomas Jefferson University

Philadelphia, PA


  Andrzej Wojcieszynski, MD

Assistant Professor of Radiation Oncology

Perelman School of Medicine

University of Pennsylvania

Philadelphia, PA



This educational activity has been designed to meet the needs of specialists in Oncology, Surgery, Emergency Medicine, Family Medicine, Internal Medicine, Neurology, Obstetrics & Gynecology, Pulmonary Disease, Residents, Advanced Practice Clinicians, other interested physicians, and interprofessional healthcare providers involved in cancer treatment and patient care.



2.25 AMA PRA Category 1 Credits™



4:30 pm     Sign-In, Exhibits & Dinner  

5:00 pm     Welcome & Overview  

5:15 pm     Cancer Accreditation Program: Peter Senatore, MD

5:30 pm     Jonathan Efron, MD

                  Multi-Disciplinary Approach to Rectal Cancer

6:15 pm     Steven Cohen, MD

                  What’s New in the Treatment of Metastatic Colorectal Cancer?                                        A lot!

7:00 pm     Andrzej Wojcieszynski, MD

                  The Radiation Oncologist's Role in Colorectal Cancer:                                                      Current & Upcoming Indications                                           

7:45 pm     Evaluation & Closing Remarks 




Accreditation Statement: Inspira Health is accredited by the Medical Society of New Jersey to provide continuing medical education for physicians.

Credit Designation: Inspira Health designates this live activity for a maximum of 2.25 AMA PRA Category 1 CreditsTM.

Physicians should only claim the credit commensurate with the extent of their participation in the activity.


 Are there ID requirements or an age limit to enter the event?

 Inspira Health residents and fellows must present their ID badge to confirm their free registration.

 What are my parking options at the venue?

The Luciano Conference Center at Cumberland County College is on the college campus located at 3322 College Drive in Vineland, N.J. For directions visit or call 856-691-9196. Parking for the symposium is free in lot G.

 Where can I contact the organizer with any questions?

 Susan Hansen, 856-641-7511,

 Is my registration/ticket transferrable?


 What's the refund policy?

Cancellation: A full refund minus a 20% registration cancellation fee will be granted if the cancellation is made in writing, postmarked and/or received at least 2 weeks prior to the start of the symposium. Send attn: Susan Hansen, or Inspira Health, CME Program, MSO Box #44, 1505 W. Sherman Avenue, Vineland, NJ, 08360. 

Inspira Health's CME Program reserves the right to modify the activity content, faculty, exhibits and to cancel this activity if necessary, without prior notification.


It is the policy of Inspira Health to comply with the American with Disabilities Act. If any participant of this activity has a disability that requires special accommodations, please contact Susan Hansen at or 856-641-7511 at least 2 weeks prior to the start of the symposium and we will be happy to provide assistance.


Registration fee includes access to the symposium, CME credit, buffet dinner, activity materials and exhibits.

Have questions about 2019 Cancer Symposium: Advances in Colorectal Cancer Treatment? Contact Inspira Health - Continuing Medical Education Program

When & Where

Cumberland County College - Luciano Conference Center
3322 College Drive
Vineland, NJ 08360

Thursday, September 26, 2019 from 4:30 PM to 8:00 PM (EDT)

  Add to my calendar


Inspira Health - Continuing Medical Education Program



Inspira's CME Program offers continuing medical education activities that assist our medical staff and interprofessional healthcare teams in acquiring the knowledge and skills needed to deliver quality healthcare to the population we serve. Our educational activities provide content intended to enhance the clinical and diagnostic skills of our healthcare providers with the goal of increased practice compliance and continuous improvement in patient care. 

Follow this link for more details about CME at Inspira Health!

  Contact the Organizer

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.